Miocamycin Explained
Miocamycin is a macrolide antibiotic.[1] It has a spectrum activity similar to that of Erythromycin, but shows higher antimicrobial effect against certain bacteria including Legionella pneumophila (the causative agent of Legionnaires' Disease), Mycoplasma hominis, and Ureaplasma urealyticum. In-vivo studies have further expounded on Miocamycin's efficacy, reporting that the medication is more effective than in-vitro data suggests.[2]
Notes and References
- Holliday SM, Faulds D . Miocamycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential . Drugs . 46 . 4 . 720–45 . October 1993 . 7506653 . 10.2165/00003495-199346040-00008 . 195692285 .
- Lyseng-Williamson . Katherine A . June 2006 . Miocamycin is an effective option in the treatment of various bacterial infections . Drugs & Therapy Perspectives . en . 22 . 6 . 1–6 . 10.2165/00042310-200622060-00001 . 72178165 . 1172-0360.